Trump’s Plan to Lower Drug Prices in U.S. Is Leading to Fewer New Drugs in Europe
An analysis shows that 27% fewer drugs launched in Europe since President Trump’s international drug-pricing policy began.
We haven't written up this one. Hindustan Times - World News has the full story — the link below goes straight to it.